Shay Capital LLC Lumos Pharma, Inc. Transaction History
Shay Capital LLC
- $608 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding LUMO
# of Institutions
6Shares Held
168KCall Options Held
0Put Options Held
0-
Jefferies Group LLC New York, NY121KShares$523,6250.01% of portfolio
-
Black Rock Inc. New York, NY41.1KShares$178,3910.0% of portfolio
-
Urban Wealth Management, LLC3.49KShares$15,1460.09% of portfolio
-
American Portfolios Advisors Holbrook, NY1.25KShares$5,4250.0% of portfolio
-
Wipfli Financial Advisors Llc,1.01KShares$4,3870.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...